
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17720437
[patent_doc_number] => 20220213157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/656221
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656221 | ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS | Mar 22, 2022 | Pending |
Array
(
[id] => 17852255
[patent_doc_number] => 20220282297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E
[patent_app_type] => utility
[patent_app_number] => 17/697043
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697043 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | Mar 16, 2022 | Pending |
Array
(
[id] => 17688109
[patent_doc_number] => 20220195401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => MODIFIED PIGGYBAC TRANSPOSASE POLYPEPTIDE, POLYNUCLEOTIDE ENCODING THEM, INTRODUCING CARRIER, KIT, METHOD OF INCORPORATING TARGET SEQUENCE INTO CELL GENOME, AND METHOD OF PRODUCING CELL
[patent_app_type] => utility
[patent_app_number] => 17/692857
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692857 | MODIFIED PIGGYBAC TRANSPOSASE POLYPEPTIDE, POLYNUCLEOTIDE ENCODING THEM, INTRODUCING CARRIER, KIT, METHOD OF INCORPORATING TARGET SEQUENCE INTO CELL GENOME, AND METHOD OF PRODUCING CELL | Mar 10, 2022 | Pending |
Array
(
[id] => 17850528
[patent_doc_number] => 20220280569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/691778
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691778 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Mar 9, 2022 | Issued |
Array
(
[id] => 19778755
[patent_doc_number] => 12227779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA
[patent_app_type] => utility
[patent_app_number] => 17/690657
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 47629
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690657 | Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA | Mar 8, 2022 | Issued |
Array
(
[id] => 17671020
[patent_doc_number] => 20220184187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => Combination treatment for atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 17/687789
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687789 | Combination treatment for atopic dermatitis | Mar 6, 2022 | Abandoned |
Array
(
[id] => 17671020
[patent_doc_number] => 20220184187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => Combination treatment for atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 17/687789
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687789 | Combination treatment for atopic dermatitis | Mar 6, 2022 | Abandoned |
Array
(
[id] => 17671020
[patent_doc_number] => 20220184187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => Combination treatment for atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 17/687789
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687789 | Combination treatment for atopic dermatitis | Mar 6, 2022 | Abandoned |
Array
(
[id] => 19354324
[patent_doc_number] => 12054755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/683299
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 10164
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683299 | None | Feb 27, 2022 | Issued |
Array
(
[id] => 18182839
[patent_doc_number] => 20230043569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN
[patent_app_type] => utility
[patent_app_number] => 17/683123
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683123 | PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN | Feb 27, 2022 | Pending |
Array
(
[id] => 17665506
[patent_doc_number] => 11359187
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-14
[patent_title] => Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
[patent_app_type] => utility
[patent_app_number] => 17/680279
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 26596
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680279 | Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells | Feb 23, 2022 | Issued |
Array
(
[id] => 19043807
[patent_doc_number] => 11932894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Method for producing albicanol and/or drimenol
[patent_app_type] => utility
[patent_app_number] => 17/673465
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20895
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673465 | Method for producing albicanol and/or drimenol | Feb 15, 2022 | Issued |
Array
(
[id] => 19043807
[patent_doc_number] => 11932894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Method for producing albicanol and/or drimenol
[patent_app_type] => utility
[patent_app_number] => 17/673465
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20895
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673465 | Method for producing albicanol and/or drimenol | Feb 15, 2022 | Issued |
Array
(
[id] => 19609599
[patent_doc_number] => 12158471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Recombinant amebocyte lysate and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/650803
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 18899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650803 | Recombinant amebocyte lysate and uses thereof | Feb 10, 2022 | Issued |
Array
(
[id] => 17800405
[patent_doc_number] => 11414690
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-16
[patent_title] => Uridine diphosphate glycosyltransferase and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/650591
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10475
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650591 | Uridine diphosphate glycosyltransferase and use thereof | Feb 9, 2022 | Issued |
Array
(
[id] => 18955570
[patent_doc_number] => 20240043897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SUBTILISIN VARIANTS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/264101
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264101
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264101 | SUBTILISIN VARIANTS AND THEIR USE | Feb 8, 2022 | Pending |
Array
(
[id] => 18955570
[patent_doc_number] => 20240043897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SUBTILISIN VARIANTS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/264101
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264101
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264101 | SUBTILISIN VARIANTS AND THEIR USE | Feb 8, 2022 | Pending |
Array
(
[id] => 17627562
[patent_doc_number] => 20220162577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS AND COMPOSITIONS FOR REDUCING BACTERIAL LOAD IN TABACCO
[patent_app_type] => utility
[patent_app_number] => 17/665968
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665968 | Methods and compositions for reducing bacterial load in tobacco | Feb 6, 2022 | Issued |
Array
(
[id] => 18658023
[patent_doc_number] => 20230303989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => OMNI-103 CRISPR NUCLEASE
[patent_app_type] => utility
[patent_app_number] => 18/006372
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006372 | OMNI-103 CRISPR nuclease | Feb 6, 2022 | Issued |
Array
(
[id] => 18996182
[patent_doc_number] => 11913014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/665856
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15708
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665856 | None | Feb 6, 2022 | Issued |